SARS News and Research

RSS

Factors predicting cognitive symptoms in long COVID

The researchers focused on finding risk factors for long-term symptom occurrence and severity, with special attention to cognitive impairment.

1 Nov 2021

Study suggests increased pediatric COVID-19 hospitalizations related to increased Delta variant incidence

The current study compares the severity of the illness in children infected by the wild-type strain compared with the VOC now prevalent in terms of outcomes in this age group.

1 Nov 2021

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.

1 Nov 2021

The effect of mass vaccination on COVID-19 mortality in Israel

A team of scientists from Israel and the USA has recently examined the efficacy of coronavirus disease 2019 (COVID-19) vaccination in reducing the death risk among people aged 70 years and above. They observe that despite government-imparted relaxation on non-pharmaceutical control measures, the vaccine saved more lives than expected by individual-level vaccine efficacy.

1 Nov 2021

Alteration in gut microbiome may lead to hyperinflammation in severe COVID-19

A team of international scientists has recently identified a distinct set of proinflammatory mediators and metabolites associated with the fatal consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, they have established a link between gut microbiome alteration and hyper-inflammatory response in patients with severe COVID-19. The study is currently available on the bioRxiv* preprint server.

1 Nov 2021

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

A recent study published in the journal Cellular & Molecular Immunology shows that a new A.30 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can evade vaccine-induced antibodies and might spread outside the lungs extraordinarily well, with important implications for our public health response.

1 Nov 2021

Study shows COVID vaccination highly protective against death, especially for older age groups

Researchers from the UK used EAVE II, an individual-level, national surveillance system, to determine the frequency of COVID-19-related fatalities among fully vaccinated individuals and to define the clinical and demographic characteristics of COVID-19 deaths in fully vaccinated individuals since the beginning of the COVID-19 vaccination program in Scotland.

1 Nov 2021

Pregnant and breastfeeding women's perceptions and concerns about COVID-19 vaccines

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is one of the most important ways of fighting the ongoing COVID-19 pandemic, the recommendations for vaccination for pregnant and breastfeeding women are not consistent.

1 Nov 2021

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Research published in the journal Nature Medicine suggests a risk for neurological complications after the first shot of a COVID-19 vaccine. However, the likelihood of developing neurological complications remains far greater among people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

31 Oct 2021

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

A new study demonstrates the influence of prior infectious outbreaks in a large population on succeeding pandemic outcomes.

31 Oct 2021

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

A new study explores the role of new SARS-CoV-2 variants in sustaining the pandemic in South Africa.

31 Oct 2021

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.

31 Oct 2021

New Canadian serology solution for SARS-CoV-2 infections and vaccination

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

31 Oct 2021

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.

31 Oct 2021

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

Largest real-world study evaluates the effectiveness of third "booster" dose of COVID-19 vaccine

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the third dose of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2.

30 Oct 2021

SARS News and Research

Factors predicting cognitive symptoms in long COVID

Study suggests increased pediatric COVID-19 hospitalizations related to increased Delta variant incidence

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

The effect of mass vaccination on COVID-19 mortality in Israel

Alteration in gut microbiome may lead to hyperinflammation in severe COVID-19

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Study shows COVID vaccination highly protective against death, especially for older age groups

Pregnant and breastfeeding women's perceptions and concerns about COVID-19 vaccines

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

New Canadian serology solution for SARS-CoV-2 infections and vaccination

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

The ability of natural flavonoids to inhibit SARS-CoV-2

Largest real-world study evaluates the effectiveness of third "booster" dose of COVID-19 vaccine

Harnessing the genetics of hookworms to develop next generation of PPE for combat troops

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

Opening schools for in-person learning not linked with increase in COVID-19 case rates

Children and adults have similar risks of SARS-CoV-2 infection, but kids do not show symptoms

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News